Akoya Biosciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
AKYA Nasdaq 3841 https://www.akoyabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akoya Biosciences Inc

Akoya Biosciences Announces Leadership Transition - Mar 20th, 2023 8:00 pm
Akoya Biosciences Full Year 2022 Earnings: EPS Misses Expectations - Mar 9th, 2023 10:17 am
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2022 Earnings Call Transcript - Mar 8th, 2023 12:21 pm
Q4 2022 Akoya Biosciences Inc Earnings Call - Mar 7th, 2023 2:52 pm
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates - Mar 6th, 2023 10:35 pm
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance - Mar 6th, 2023 9:05 pm
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel - Feb 28th, 2023 1:00 pm
Will Akoya Biosciences (AKYA) Report Negative Earnings Next Week? What You Should Know - Feb 27th, 2023 3:00 pm
Argo Group and Akoya Biosciences Stock See Action From Activist Investors - Feb 10th, 2023 11:36 pm
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences - Feb 6th, 2023 1:05 pm
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting - Feb 1st, 2023 1:00 pm
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022 - Jan 8th, 2023 9:00 pm
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications - Jan 6th, 2023 1:00 pm
Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference - Dec 28th, 2022 9:00 pm
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day - Dec 15th, 2022 9:00 pm
Institutions own 23% of Akoya Biosciences, Inc. (NASDAQ:AKYA) shares but private equity firms control 49% of the company - Dec 7th, 2022 10:15 am
Akoya Biosciences (AKYA) Reports Q3 Loss, Tops Revenue Estimates - Nov 7th, 2022 10:25 pm
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy - Nov 7th, 2022 9:05 pm
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance - Nov 7th, 2022 9:05 pm
Akoya to Participate at Three Upcoming Investor Conferences - Nov 3rd, 2022 12:05 pm